Multiparameter analysis using cell cycle biomarkers for small-size lung adenocarcinoma: prognostic implications
Authors:
Open Access
- 3 July 2012
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 28 (3) , 915-922
Abstract
Cell cycle-related molecules play crucial roles in maintaining genomic stability, and can also serve as biomarkers of cell cycle phase distribution at the same time. In this study, we used multiparameter analysis of various biomarkers to investigate their utility for the evaluation of tumor proliferation activities and the prognosis of patients with small-size lung adenocarcinoma. We performed immunohistochemical analysis using five cell cycle-related biomarkers (MCM7, Ki-67, Geminin, Aurora A and H3S10ph) for 102 surgically resected small-size lung adenocarcinomas. We classified them into three phenotypes based on the dominant cell cycle phase distribution of the tumor cell population, and evaluated whether these phenotypes were associated with clinicopathological factors and survival. Phenotype I (MCM7-negative tumors; n=56) was correlated with high or moderate differentiation and reduced local invasiveness (pleural and lymphovascular invasion) compared with phenotype II (MCM7-, Ki-67- and Geminin-positive tumors; n=23) and phenotype III (MCM7-, Aurora A- and H3S10ph-positive tumors; n=17). Five-year survival rates of phenotypes I, II and III were 89.8, 55.4 and 38.6%, respectively, with a significant difference between them (p<0.01). Multivariate analysis revealed that phenotypes II and III were independent prognostic factors in the 79 patients with stage I lung adenocarcinoma. Multiparameter analysis using cell cycle biomarkers for small-size lung adenocarcinoma provided novel insights into the cell cycle phase distribution of dynamic tumor cell populations in vivo; it may be possible to evaluate tumor proliferation activities and patient prognosis more precisely if this analytical procedure is used.Keywords
This publication has 36 references indexed in Scilit:
- Expression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): Prognostic implicationLung Cancer, 2009
- Aurora kinase expression in colorectal adenocarcinoma: correlations with clinicopathological features, p16 expression, and telomerase activityHuman Pathology, 2008
- Minichromosome maintenance 2 (MCM2) immunoreactivity in stage III human gastric carcinoma: clinicopathological significanceGastric Cancer, 2008
- Cell cycle markers in clinical oncologyCurrent Opinion in Cell Biology, 2007
- Significance of Aurora-A expression in renal cell carcinomaUrologic Oncology: Seminars and Original Investigations, 2007
- The regulation of embryonic patterning and DNA replication by gemininCellular and Molecular Life Sciences, 2005
- Geminin predicts adverse clinical outcome in breast cancer by reflecting cell‐cycle progressionThe Journal of Pathology, 2004
- Ki-67 expression and prognosis for smokers with resected stage i Non–Small cell lung cancerThe Annals of Thoracic Surgery, 2003
- Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lungThe Annals of Thoracic Surgery, 2000
- Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: A comparative studyActa Neuropathologica, 1991